IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway

References

• Chen J, Gao C, Zhu W. Long non-coding RNA SLC25A25-AS1 exhibits oncogenic roles in non-small cell lung cancer by regulating the microRNA-195-5p/ITGA2 axis. Oncol Lett. 2021;22(1):529. doi: 10.3892/ol.2021.12790
   PubMed Web of Science ®Google Scholar
• Chen J, Wang R, Zhang K, et al. Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets. J Cell Mol Med. 2014;18(12):2425–18. doi: 10.1111/jcmm.12431
   PubMed Web of Science ®Google Scholar
• Tandberg DJ, Tong BC, Ackerson BG, et al. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: a comprehensive review. Cancer. 2018;124(4):667–678. doi: 10.1002/cncr.31196
   PubMed Web of Science ®Google Scholar
• Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol. 2007;8(9):784–796. doi: 10.1016/S1470-2045(07)70246-2
   PubMed Web of Science ®Google Scholar
• Yoshida GJ. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways. J Exp Clin Cancer Res. 2020;39(1):112. doi: 10.1186/s13046-020-01611-0
   PubMed Web of Science ®Google Scholar
• Fang T, Lv H, Lv G, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018;9(1):191. doi: 10.1038/s41467-017-02583-0
   PubMed Web of Science ®Google Scholar
• Chen G, Huang AC, Zhang W, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018;560(7718):382–386. doi: 10.1038/s41586-018-0392-8
   PubMed Web of Science ®Google Scholar
• Sun C, Mezzadra R, Schumacher TN. Regulation and function of the PD-L1 checkpoint. Immunity. 2018;48(3):434–452. doi: 10.1016/j.immuni.2018.03.014
   PubMed Web of Science ®Google Scholar
• Burr ML, Sparbier CE, Chan YC, et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature. 2017;549(7670):101–105. doi: 10.1038/nature23643
   PubMed Web of Science ®Google Scholar
• Tsoukalas N, Kiakou M, Tsapakidis K, et al. PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer. J Buon. 2019;24(3):883–888.
   PubMed Web of Science ®Google Scholar
• Hastings MH. m(6)A mRNA methylation: a new circadian pacesetter. Cell. 2013;155(4):740–741. doi: 10.1016/j.cell.2013.10.028
   PubMed Web of Science ®Google Scholar
• Zeng C, Huang W, Li Y, et al. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020;13(1):117. doi: 10.1186/s13045-020-00951-w
   PubMed Web of Science ®Google Scholar
• Li T, Hu PS, Zuo Z, et al. METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma. Mol Cancer. 2019;18(1):112. doi: 10.1186/s12943-019-1038-7
   PubMed Web of Science ®Google Scholar
• Ni Z, Sun P, Zheng J, et al. JNK Signaling promotes bladder cancer immune escape by regulating METTL3-mediated m6A modification of PD-L1 mRNA. Cancer Res. 2022;82(9):1789–1802. doi: 10.1158/0008-5472.CAN-21-1323
   PubMed Web of Science ®Google Scholar
• Park OH, Ha H, Lee Y, et al. Endoribonucleolytic cleavage of m(6)A-Containing RNAs by RNase P/MRP complex. Molecular Cell. 2019;74(3):494–507.e8. doi: 10.1016/j.molcel.2019.02.034
   PubMed Web of Science ®Google Scholar
• Du H, Zhao Y, He J, et al. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun. 2016;7:12626. doi: 10.1038/ncomms12626
   PubMed Web of Science ®Google Scholar
• Yu J, Chai P, Xie M, et al. Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Bio. 2021;22(1):85. doi: 10.1186/s13059-021-02308-z
   PubMed Web of Science ®Google Scholar
• Jia Y, Zang A, Jiao S, et al. The interleukin-18 gene promoter -607 A/C polymorphism contributes to non-small-cell lung cancer risk in a Chinese population. Onco Targets Ther. 2016;9:1715–1719. doi: 10.2147/OTT.S99581
   PubMed Web of Science ®Google Scholar
• Park IH, Yang HN, Lee KJ, et al. Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer. Oncotarget. 2017;8(20):32722–32730. doi: 10.18632/oncotarget.16281
   PubMedGoogle Scholar
• Ge P, Xiao G. Interleukin-27 rs153109 polymorphism and the risk of non-small-cell lung cancer in a Chinese population. Onco Targets Ther. 2016;9:895–898. doi: 10.2147/OTT.S93226
   PubMed Web of Science ®Google Scholar
• Chen B, Yang M, Li K, et al. Immune-related genes and gene sets for predicting the response to anti-programmed death 1 therapy in patients with primary or metastatic non-small cell lung cancer. Oncol Lett. 2021;22(1):540. doi: 10.3892/ol.2021.12801
   PubMed Web of Science ®Google Scholar
• Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5(10):749–759. doi: 10.1038/nri1703
   PubMed Web of Science ®Google Scholar
• Zhou Y, Jin X, Yu H, et al. HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer. Theranostics. 2022;12(5):2080–2094. doi: 10.7150/thno.69444
   PubMed Web of Science ®Google Scholar
• Meng H, Gong J, Fang L, et al. Effect of interferon-γ on NF-κB and cytokine IL-18 and IL-27 in acute pancreatitis. Bosn J of Basic Med Sci. 2013;13(2):114–118. doi: 10.17305/bjbms.2013.2391
   PubMed Web of Science ®Google Scholar
• Pelon F, Bourachot B, Kieffer Y, et al. Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms. Nat Commun. 2020;11(1):404. doi: 10.1038/s41467-019-14134-w
   PubMed Web of Science ®Google Scholar
• Han J, Wang JZ, Yang X, et al. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Mol Cancer. 2019;18(1):110. doi: 10.1186/s12943-019-1036-9
   PubMed Web of Science ®Google Scholar
• Bartoschek M, Oskolkov N, Bocci M, et al. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun. 2018;9(1):5150. doi: 10.1038/s41467-018-07582-3
   PubMed Web of Science ®Google Scholar
• Cao X, Cai SF, Fehniger TA, et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity. 2007;27(4):635–646. doi: 10.1016/j.immuni.2007.08.014
   PubMed Web of Science ®Google Scholar
• Wawrocki S, Druszczynska M, Kowalewicz-Kulbat M, et al. Interleukin 18 (IL-18) as a target for immune intervention. Acta Biochim Pol. 2016;63(1):59–63. doi: 10.18388/abp.2015_1153
   PubMed Web of Science ®Google Scholar
• Zhou T, Damsky W, Weizman OE, et al. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. Nature. 2020;583(7817):609–614. doi: 10.1038/s41586-020-2422-6
   PubMed Web of Science ®Google Scholar
• Zhang W, Bouchard G, Yu A, et al. GFPT2-expressing cancer-associated fibroblasts mediate metabolic reprogramming in Human lung adenocarcinoma. Cancer Res. 2018;78(13):3445–3457. doi: 10.1158/0008-5472.CAN-17-2928
   PubMed Web of Science ®Google Scholar
• Brody R, Zhang Y, Ballas M, et al. PD-L1 expression in advanced NSCLC: insights into risk stratification and treatment selection from a systematic literature review. Lung Cancer. 2017;112:200–215. doi: 10.1016/j.lungcan.2017.08.005
   PubMed Web of Science ®Google Scholar
• Zhou X, Yan T, Huang C, et al. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway. J Exp Clin Cancer Res. 2018;37(1):242. doi: 10.1186/s13046-018-0911-3
   PubMed Web of Science ®Google Scholar
• Aoyama T, Yamashita S, Tomita K. Mechanistic insights into m6A modification of U6 snRNA by human METTL16. Nucleic Acids Res. 2020;48(9):5157–5168. doi: 10.1093/nar/gkaa227
   PubMed Web of Science ®Google Scholar
• Warda AS, Kretschmer J, Hackert P, et al. Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRnas and various non-coding RNAs. EMBO Rep. 2017;18(11):2004–2014. doi: 10.15252/embr.201744940
   PubMed Web of Science ®Google Scholar
• Xiong J, He J, Zhu J, et al. Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Molecular Cell. 2022;82(9):1660–77.e10. doi: 10.1016/j.molcel.2022.02.033
   PubMed Web of Science ®Google Scholar
• Avanzi MP, Yeku O, Li X, et al. Engineered tumor-Targeted T cells Mediate enhanced anti-tumor Efficacy Both directly and through activation of the endogenous immune System. Cell Rep. 2018;23(7):2130–2141. doi: 10.1016/j.celrep.2018.04.051
   PubMed Web of Science ®Google Scholar
• Li J, Xie H, Ying Y, et al. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Mol Cancer. 2020;19(1):152. doi: 10.1186/s12943-020-01267-6
   PubMed Web of Science ®Google Scholar
• Dixit D, Prager BC, Gimple RC, et al. The RNA m6A reader YTHDF2 Maintains Oncogene expression and is a targetable dependency in glioblastoma stem cells. Cancer Discov. 2021;11(2):480–499. doi: 10.1158/2159-8290.CD-20-0331
   PubMed Web of Science ®Google Scholar
• Mulero MC, Huxford T, NF-Κb GG. IκB, and IKK: integral components of immune System Signaling. Adv Exp Med Biol. 2019;1172:207–226.
   PubMed Web of Science ®Google Scholar
• Paul S, Traver MK, Kashyap AK, et al. T cell receptor signals to NF-κB are transmitted by a cytosolic p62-Bcl10-Malt1-IKK signalosome. Sci Signal. 2014;7(325):ra45. doi: 10.1126/scisignal.2004882
   PubMed Web of Science ®Google Scholar
• Jin X, Ding D, Yan Y, et al. Phosphorylated RB promotes cancer immunity by inhibiting NF-κB activation and PD-L1 expression. Molecular Cell. 2019;73(1):22–35.e6. doi: 10.1016/j.molcel.2018.10.034
   PubMed Web of Science ®Google Scholar